References
- Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001;56:607-620 https://doi.org/10.1053/crad.2001.0762
- Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadoliniumbased MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649 https://doi.org/10.1148/radiol.2423061640
- Kanda T, Fukusato T, Matsuda M, et al. Gadolinium-based contrast agent accumulates in the brain Even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 2015;276:228-232 https://doi.org/10.1148/radiol.2015142690
- Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006;35:512-523 https://doi.org/10.1039/b510982p
- Trattnig S, Marlovits S, Gebetsroither S, et al. Threedimensional delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) for in vivo evaluation of reparative cartilage after matrix-associated autologous chondrocyte transplantation at 3.0T: Preliminary results. J Magn Reson Imaging 2007;26:974-982 https://doi.org/10.1002/jmri.21091
- Sasaki M, Shibata E, Kanbara Y, Ehara S. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study. Magn Reson Med Sci 2005;4:145-149 https://doi.org/10.2463/mrms.4.145
- Robson MD, Gatehouse PD, Bydder M, Bydder GM. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J Comput Assist Tomogr 2003;27:825-846 https://doi.org/10.1097/00004728-200311000-00001
- Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-571 https://doi.org/10.1002/mrm.1910310516
- Li W, Avram AV, Wu B, Xiao X, Liu C. Integrated Laplacianbased phase unwrapping and background phase removal for quantitative susceptibility mapping. NMR Biomed 2014;27:219-227 https://doi.org/10.1002/nbm.3056
- Poselt E, Kloust H, Tromsdorf U, et al. Relaxivity optimization of a PEGylated iron-oxide-based negative magnetic resonance contrast agent for T(2)-weighted spinecho imaging. ACS Nano 2012;6:1619-1624 https://doi.org/10.1021/nn204591r
- Sosnovik DE, Nahrendorf M, Weissleder R. Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol 2008;103:122-130 https://doi.org/10.1007/s00395-008-0710-7
Cited by
- Efficient Experimental Design for Measuring Magnetic Susceptibility of Arbitrarily Shaped Materials by MRI vol.22, pp.3, 2017, https://doi.org/10.13104/imri.2018.22.3.141
- Analysis of Diluted Contrast Medium Injection Effect in Magnetic Resonance Angiography on the Head and Neck Imaging vol.30, pp.2, 2017, https://doi.org/10.31159/ksmrt.2020.30.2.25
- MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study vol.297, pp.1, 2017, https://doi.org/10.1148/radiol.2020192579